Life Tech Acquires AcroMetrix to Gain QC Reagents for Real-Time PCR, other Molecular Dx Assays

Life Tech officials said they expect the deal to complement its company's real-time PCR business in the short term and help expand its presence in the broader molecular diagnostics market in the longer term.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.